This article originally appeared on the New Zealand Herald Website on the 26th of September, 2017. A 44-year-old father of four given six to nine months to live when he was diagnosed with lung cancer has seen his tumour halve in size thanks to a new treatment he describes as a “miracle drug”. Patients and … Continue reading SHOULD ‘MIRACLE’ DRUGS LIKE KEYTRUDA BE FUNDED?